FDA Inspection 861305 — Orthofix U.S. LLC

Orthofix U.S. LLC — FEI 2183449

The FDA completed an inspection of Orthofix U.S. LLC on Jan 3, 2014 in Lewisville, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 3, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Lewisville, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.